21 C.F.R. § 862.1185

Compound S (11-deoxycortisol) test system.

Last amended: 2016Year: 2026Length: 105 wordsSubsections: 1Official source

Cite as 21 C.F.R. § 862.1185 (2026)

(a) Identification. A compound S (11-dioxycortisol) test system is a device intended to measure the level of compound S (11-dioxycortisol) in plasma. Compound S is a steroid intermediate in the biosynthesis of the adrenal hormone cortisol. Measurements of compound S are used in the diagnosis and treatment of certain adrenal and pituitary gland disorders resulting in clinical symptoms of masculinization and hypertension. (b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9. [52 FR 16122, May 1, 1987, as amended at 65 FR 2305, Jan. 14, 2000]
Cross-references to the CFR
862.9.
21 C.F.R. § 862.1185: Compound S (11-deoxycortisol) test system. | Justis AI